Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 1.65 Delayed Data As of 3:58pm ET |  0.00 / 0.00%Today’s Change | 1.29 Today|||52-Week Range 14.00 | -15.82% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for Cymabay Therapeutics Inc.
Today’s Trading
| Previous close | 1.65 |
| Today’s open | 1.61 |
| Day’s range | 1.55 - 1.65 |
| Volume | 891,250 |
| Average volume (3 months) | 1,910,072 |
| Market cap | $122.3M |
Data as of 3:58pm ET, 02/28/2020
Growth & Valuation
| Earnings growth (last year) | -58.86% |
| Earnings growth (this year) | -18.86% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DITAMCON Distributing C... | -0.87 | -1.19% |
| NUSNU Skin Enterprises ... | -0.30 | -1.21% |
| HLFHerbalife Nutrition ... | -0.04 | -0.12% |
| CAHCardinal Health Inc | -0.19 | -0.36% |
Data as of 4:09pm ET, 02/28/2020
Financials
| Next reporting date | March 18, 2020 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$72.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
